This suggests that the low expression of TIMP4 may be related to muscle atrophy, and bevacizumab may reduce the expression of timp4.Given that its association with muscle atrophy has not been definitively reported, more research is needed to determine. The gene discussed is TIMP4; the disease is muscle atrophy.